These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 4213282

  • 1. Outpatient intravenous medications in the management of cystic fibrosis.
    Rucker RW, Harrison GM.
    Pediatrics; 1974 Sep; 54(3):358-60. PubMed ID: 4213282
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Eradication of Pseudomonas aeruginosa in cystic fibrosis.
    Eber E, Thalhammer GH, Zach MS.
    Eur Respir J; 2006 Feb; 27(2):438-9. PubMed ID: 16452606
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Home intravenous therapy using a silastic long line catheter in cystic fibrosis patients.
    Pradeepkumar VK, Waseem E, Shortt C, Barry D, Watson JB.
    Ir Med J; 1992 Sep; 85(3):110-1. PubMed ID: 1399475
    [Abstract] [Full Text] [Related]

  • 10. Changes in lung function in young cystic fibrosis patients between two courses of intravenous antibiotics against Pseudomonas aeruginosa.
    Béghin L, Michaud L, Loeuille GA, Wizla-Derambure N, Sayah H, Sardet A, Thumerelle C, Deschildre A, Turck D, Gottrand F.
    Pediatr Pulmonol; 2009 May; 44(5):464-71. PubMed ID: 19360849
    [Abstract] [Full Text] [Related]

  • 11. Safety and tolerability of bolus intravenous colistin in acute respiratory exacerbations in adults with cystic fibrosis.
    Conway SP, Etherington C, Munday J, Goldman MH, Strong JJ, Wootton M.
    Ann Pharmacother; 2000 Nov; 34(11):1238-42. PubMed ID: 11098334
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Implementation of European standards of care for cystic fibrosis--control and treatment of infection.
    Elborn JS, Hodson M, Bertram C.
    J Cyst Fibros; 2009 May; 8(3):211-7. PubMed ID: 19372063
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Editorial overview: clinical utility of synergy testing for multidrug resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
    Middleton PG.
    Paediatr Respir Rev; 2007 Sep; 8(3):262-3, quiz 263-4. PubMed ID: 17868925
    [No Abstract] [Full Text] [Related]

  • 16. Duration of intravenous antibiotic treatment for respiratory exacerbations in children with cystic fibrosis.
    Brown SM, Balfour-Lynn IM.
    Arch Dis Child; 2010 Jul; 95(7):568. PubMed ID: 20522458
    [No Abstract] [Full Text] [Related]

  • 17. [Anti-Pseudomonas aerosol therapy in cystic fibrosis: improvement with tobramycin].
    Foucaud P, Borel B, Charara O, Nathanson S, Petitprez P, Pin I.
    Rev Pneumol Clin; 2002 Jun; 58(3 Pt 1):131-8. PubMed ID: 12486796
    [Abstract] [Full Text] [Related]

  • 18. [How should chronic Pseudomonas aeruginosa bronchial infection be treated in the course of cystic fibrosis?].
    Hubert D, Desmazes-Dufeu N, Dusser D.
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S129-35. PubMed ID: 12910145
    [No Abstract] [Full Text] [Related]

  • 19. The approach to Pseudomonas aeruginosa in cystic fibrosis.
    Bendiak GN, Ratjen F.
    Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
    [Abstract] [Full Text] [Related]

  • 20. [Ochrobactrum anthropi bacteremia in a child with cystic fibrosis].
    Yagüe-Muñoz A, Gregori-Roig P, Valls-López S, Pantoja-Martínez J.
    Enferm Infecc Microbiol Clin; 2010 Feb; 28(2):137-8. PubMed ID: 19811858
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.